Patients were considered treated for elevated BP if one or more of their prescribed drugs were of the following classes: diuretics, beta-blockers, angiotensin-converting enzyme inhibitors, angiotensin II receptor blockers, calcium channel blockers, alpha blockers, alpha-2 receptor agonists, combined alpha and beta-blockers, central agonists, peripheral adrenergic inhibitors,
or vasodilators. If a drug name was classified as a statin, selective cholesterol adsorption inhibitors, resins, or lipid-lowering therapy drug, we considered the patient to be treated for high cholesterol. Patients treated for diabetes mellitus were those prescribed drugs from the insulin, sulfonylureas, iguanids, meglitinides, thiazolidinediones, DPP-4 inhibitors, SGLT2 inhibitors, alpha-glucosidase inhibitors, or bile acid sequestrants classes of medications.
For observations recording BMI, we excluded 113,718 because they did not fall within our timeframe of analysis, 23,982 due to implausible values, 91,725 due to lack of age information, 158,932 due to missing values, 669,111 due to repeat measurement within that year, and 4,539 because the patient was <18 years old. For observations recording BP, we excluded 72,983 because they did not fall within our timeframe of analysis, 49,751 due to implausible values, 177,238 due to lack of age information, 78,068 due to missing values, 1,220,935 due to repeat measurement within that year, and 8291 because the patient was <18 years old, and 45,429 due to lack of medication data. For observations recording LDL, we excluded 38,752 because they did not fall within our timeframe of analysis, 17,945 due to implausible values, 2,270 due to lack of age information, 5,009 due to missing values, 92,351 due to repeat measurement within that year, 399 because the patient was <18 years old, and 7,673 due to lack of medication data. For observations recording HbA1c, we excluded 19,738 because they did not fall within our timeframe of analysis, 17,555 due to implausible values, 58,310 due to lack of age information, 3,293 due to missing values, 88,056 due to repeat measurement within that year, 275 because the patient was <18 years old, and 3,415 due to lack of medication data.
For observations recording smoking status, we excluded 150,185 because they did not fall within our timeframe of analysis, 2,145,768 due to missing data, 63,557 due to lack of age information, 643,561 due to repeat measurement within that year, and 6,873 because the patient was <18 years old. 
